NRx Pharmaceuticals (Nasdaq:NRXP) Announces Promising Findings in Phase 2b/3 Clinical Trial of NRX-101 vs ... - StreetInsider.com

Submitted by Anonymous (not verified) on Tue, 04/30/2024 - 12:30

NRx Pharmaceuticals (Nasdaq:NRXP) Announces Promising Findings in Phase 2b/3 Clinical Trial of NRX-101 vs ...  StreetInsider.com